Related references
Note: Only part of the references are listed.Targeting the PI3K pathway in cancer: are we making headway?
Filip Janku et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells
Lara Gibellini et al.
FRONTIERS IN ONCOLOGY (2018)
A unique tolerizing dendritic cell phenotype induced by the synthetic triterpenoid CDDO-DFPA (RTA-408) is protective against EAE
Hsi-Ju Wei et al.
SCIENTIFIC REPORTS (2017)
Emerging role of Lon protease as a master regulator of mitochondrial functions
Marcello Pinti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2016)
CDDO-Me reveals USP7 as a novel target in ovarian cancer cells
Dongjun Qin et al.
ONCOTARGET (2016)
CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages
Michael S. Ball et al.
PLOS ONE (2016)
Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma
Yan Zhao et al.
BIOMATERIALS (2015)
Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer
Marcello Pinti et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Antimicrobial Activity of Oleanolic and Ursolic Acids: An Update
Jessica A. Jesus et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Natural Compounds Modulating Mitochondrial Functions
Lara Gibellini et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Anticancer and apoptotic activities of oleanolic acid are mediated through cell cycle arrest and disruption of mitochondrial membrane potential in HepG2 human hepatocellular carcinoma cells
Yue-Yong Zhu et al.
MOLECULAR MEDICINE REPORTS (2015)
Inhibition of Lon protease by triterpenoids alters mitochondria and is associated to cell death in human cancer cells
Lara Gibellini et al.
ONCOTARGET (2015)
Oleanolic acid suppresses the proliferation of lung carcinoma cells by miR-122/Cyclin G1/MEF2D axis
Xiaoming Zhao et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Antimicrobial Action of Oleanolic Acid on Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis
Sejeong Kim et al.
PLOS ONE (2015)
Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl
Melanie P. Chin et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells
Lara Gibellini et al.
FASEB JOURNAL (2014)
Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl
Melanie P. Chin et al.
JOURNAL OF CARDIAC FAILURE (2014)
Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis
Sung Hee Choi et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice
Leo R. Fitzpatrick et al.
INFLAMMOPHARMACOLOGY (2014)
Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)
Dick de Zeeuw et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis
Xin Wang et al.
CARCINOGENESIS (2013)
Inhibition of Telomerase Activity by Oleanane Triterpenoid CDDO-Me in Pancreatic Cancer Cells is ROS-Dependent
Dorrah Deeb et al.
MOLECULES (2013)
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficient and Scalable Synthesis of Bardoxolone Methyl (CDDO-methyl Ester)
Liangfeng Fu et al.
ORGANIC LETTERS (2013)
The Triterpenoid CDDO-Me Inhibits Bleomycin-Induced Lung Inflammation and Fibrosis
Ajit A. Kulkarni et al.
PLOS ONE (2013)
The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives
Steven H. Bernstein et al.
BLOOD (2012)
CDDO-Methyl Ester Delays Breast Cancer Development in Brca1-Mutated Mice
Eun-Hee Kim et al.
CANCER PREVENTION RESEARCH (2012)
The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor-Negative Mammary Carcinogenesis in Polyoma Middle T Mice
Kim Tran et al.
CANCER PREVENTION RESEARCH (2012)
A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas
David S. Hong et al.
CLINICAL CANCER RESEARCH (2012)
Structure and Dynamics of the Isoprenoid Pathway Network
Eva Vranova et al.
MOLECULAR PLANT (2012)
Telomerase Reverse Transcriptase (TERT) is a Therapeutic Target of Oleanane Triterpenoid CDDO-Me in Prostate Cancer
Yongbo Liu et al.
MOLECULES (2012)
Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis
N. Suh et al.
OSTEOARTHRITIS AND CARTILAGE (2012)
Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease
Karen T. Liby et al.
PHARMACOLOGICAL REVIEWS (2012)
Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis
Arie Neymotin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury
Yanhong Wei et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pablo E. Pergola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Molecular activities, biosynthesis and evolution of triterpenoid saponins
Jorg M. Augustin et al.
PHYTOCHEMISTRY (2011)
The family of terpene synthases in plants: a mid-size family of genes for specialized metabolism that is highly diversified throughout the kingdom
Feng Chen et al.
PLANT JOURNAL (2011)
Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis
Tej K. Pareek et al.
SCIENTIFIC REPORTS (2011)
Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer
Xiaohua Gao et al.
Cancers (2011)
Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway
Keinosuke Ryu et al.
BMC CANCER (2010)
Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
Karen T. Liby et al.
CANCER PREVENTION RESEARCH (2010)
Role of Peroxisome Proliferator-Activated Receptor-γ and Its Coactivator DRIP205 in Cellular Responses to CDDO (RTA-401) in Acute Myelogenous Leukemia
Twee Tsao et al.
CANCER RESEARCH (2010)
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Sergei I. Grivennikov et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
NADPH Oxidase Limits Innate Immune Responses in the Lungs in Mice
Brahm H. Segal et al.
PLOS ONE (2010)
Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and Age-related Macular Degeneration
Marisol Cano et al.
VISION RESEARCH (2010)
CDDO-Me: A Novel Synthetic Triterpenoid for the Treatment of Pancreatic Cancer
Dorrah Deeb et al.
Cancers (2010)
The Triterpenoid CDDO-Imidazolide Confers Potent Protection against Hyperoxic Acute Lung Injury in Mice
Narsa M. Reddy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells
Zhenfeng Duan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Triterpenoids CDDO-Methyl Ester or CDDO-Ethyl Amide and Rexinoids LG100268 or NRX194204 for Prevention and Treatment of Lung Cancer in Mice
Karen Liby et al.
CANCER PREVENTION RESEARCH (2009)
Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease
Magali Dumont et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Pentacyclic Triterpene Distribution in Various Plants - Rich Sources for a New Group of Multi-Potent Plant Extracts
Sebastian Jaeger et al.
MOLECULES (2009)
Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription
Lichuan Yang et al.
PLOS ONE (2009)
Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice
Thomas E. Sussan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Oleanane Triterpenoid CDDO-Me Inhibits Growth and Induces Apoptosis in Prostate Cancer Cells by Independently Targeting Pro-Survival Akt and mTOR
Dorrah Deeb et al.
PROSTATE (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer
Marc L. Hyer et al.
CANCER RESEARCH (2008)
Coupling of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of death receptor 5 via a CHOP-dependent mechanism involving JNK activation
Wei Zou et al.
CANCER RESEARCH (2008)
Triterpenoid CDDO-methyl ester inhibits the janus-activated kinase-1 (JAK1)→Signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3
Rehan Ahmad et al.
CANCER RESEARCH (2008)
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl ester and the rexinoid LG100268
Karen Liby et al.
CLINICAL CANCER RESEARCH (2008)
The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection
Thi A. Tran et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Inhibition of mitochondrial metabolism by methyl-2-cyano-3,12-dioxooleana-1, 9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells
Ismael Samudio et al.
MOLECULAR CANCER THERAPEUTICS (2008)
PPARγ-active triterpenoid CDDO enhances ATRA-induced differentiation in APL
Yoko Tabe et al.
CANCER BIOLOGY & THERAPY (2007)
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer-binding protein alpha
Steffen Koschmieder et al.
BLOOD (2007)
Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-κB and Notch1 signaling
Xiaohua Gao et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry
Leonarda Troiano et al.
NATURE PROTOCOLS (2007)
Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-imidazolide
Rajesh K. Thimmulappa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Triterpenoid CDDO-Me blocks the NF-κB pathway by direct inhibition of IKKβ on Cys-179
Rehan Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A novel mechanism of action of methyl-2-cyano-3,12 dioxoolean-1,9 diene-28-oate: Direct permeabilization of the inner mitochondrial membrane to inhibit electron transport and induce apoptosis
I Samudio et al.
MOLECULAR PHARMACOLOGY (2006)
The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells
Yan Ji et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Biosynthetic diversity in plant triterpene cyclization
Dereth R. Phillips et al.
CURRENT OPINION IN PLANT BIOLOGY (2006)
2-cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer
I Samudio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells
ML Hyer et al.
CANCER RESEARCH (2005)
Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action
RD Couch et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Triterpenoid CDDO-Im downregulates PML/RARα expression in acute promyelocytic leukemia cells
T Ikeda et al.
CELL DEATH AND DIFFERENTIATION (2005)
Stabilization of nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells
J Li et al.
TOXICOLOGICAL SCIENCES (2005)
c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells
W Zou et al.
CANCER RESEARCH (2004)
Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles
K Itoh et al.
GENES TO CELLS (2003)
Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element - Degradation of Nrf2 by the 26 S proteasome
T Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases
EY Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants
AT Dinkova-Kostova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells
TA Stadheim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia
M Konopleva et al.
BLOOD (2002)
The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism
Y Ito et al.
MOLECULAR PHARMACOLOGY (2001)
Synthetic oleanane and ursane triterpenoids with modified rings A and C: A series of highly active inhibitors of nitric oxide production in mouse macrophages
T Honda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
